HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.

Abstract
Reversible phosphorylation of proteins, controlled by kinases and phosphatases, is involved in various cellular processes. Dual-specificity phosphatases (DUSPs) can dephosphorylate phosphorylated serine, threonine and tyrosine residues. This family consists of 61 members, 44 of which have been identified in human, and these 44 members are classified into six subgroups, the phosphatase and tensin homolog (PTEN) protein phosphatases (PTENs), mitogen-activated protein kinase phosphatases (MKPs), atypical DUSPs, cell division cycle 14 (CDC14) phosphatases (CDC14s), slingshot protein phosphatases (SSHs), and phosphatases of the regenerating liver (PRLs). Growing evidence has revealed dysregulation of DUSPs as one of the common phenomenons and highlighted their key roles in human cancers. Furthermore, their differential expression may be a potential biomarker for tumor prognosis. Despite this, there are still many unstudied members of DUSPs need to further explore their precise roles and mechanism in cancers. Most importantly, the systematic review is very limited on the functional/mechanistic characteristics and clinical application of DUSPs at present. In this review, the structures, functions and underlying mechanisms of DUSPs are systematically reviewed, and the molecular and functional characteristics of DUSPs in different tumor types according to the current researches are summarized. In addition, the potential roles of the unstudied members and the possible different mechanisms of DUSPs in cancer are discussed and classified based on homology alignment and structural domain analyses. Moreover, the specific characteristics of their expression and prognosis are further determined in more than 30 types of human cancers by using the online databases. Finally, their potential application in precise diagnosis, prognosis and treatment of different types of cancers, and the main possible problems for the clinical application at present are prospected.
AuthorsPing-Ping Gao, Xiao-Wei Qi, Na Sun, Yuan-Yuan Sun, Ye Zhang, Xuan-Ni Tan, Jun Ding, Fei Han, Yi Zhang
JournalBiochimica et biophysica acta. Reviews on cancer (Biochim Biophys Acta Rev Cancer) Vol. 1876 Issue 1 Pg. 188562 (08 2021) ISSN: 1879-2561 [Electronic] Netherlands
PMID33964330 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2021 Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • Mitogen-Activated Protein Kinase Phosphatases
  • Phosphoprotein Phosphatases
  • SSH1 protein, human
  • CDC14A protein, human
  • CDC14B protein, human
  • Dual-Specificity Phosphatases
  • Protein Tyrosine Phosphatases
  • PTEN Phosphohydrolase
  • PTEN protein, human
Topics
  • Biomarkers, Tumor (metabolism)
  • Disease Progression
  • Dual-Specificity Phosphatases (genetics, metabolism)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mitogen-Activated Protein Kinase Phosphatases (metabolism)
  • Neoplasms (enzymology, genetics, pathology)
  • PTEN Phosphohydrolase (metabolism)
  • Phosphoprotein Phosphatases (metabolism)
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Protein Tyrosine Phosphatases (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: